Evidence map›Paper›PMID 40023366›Full record

ArticleThe Journal of investigative dermatology2025

An Assessment of Current Clinician- and Patient-Reported Outcome Measures for Acne Scarring and Dyspigmentation: A Scoping Review.

James Choe, Rebecca Urbonas, Eric Xia, Allison Yan, Ahana Gaurav, Anne Fladger, John S Barbieri

Abstract readScoping Review
In one paragraph

Article in The Journal of investigative dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James ChoeDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Rebecca UrbonasSchmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.
Eric XiaDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Allison YanDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; The Ohio State University College of Medicine, Columbus, Ohio, USA.
Ahana GauravDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Medical College of Georgia, Augusta, Georgia.
Anne FladgerCountway Library of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
John S BarbieriDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; JAMA Dermatology, Chicago, Illinois, USA. Electronic address: jbarbieri@bwh.harvard.edu.

Funding

Applying Item Response Theory to Improve Patient Reported Outcome Use in Dermatology Clinical PracticeK23AR078930 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI John Barbieri · 2022 to 2026
$867k
NIAMS NIH HHS K23 AR078930
6 · The paper itself

Abstract

Acne-associated scarring and dyspigmentation (ie, erythema, hyperpigmentation) are common sequelae with significant psychosocial impact, but little is known about what measures are most often used to assess these outcomes. This scoping review evaluates the use of current patient-reported outcome measures (PROMs) and clinician-reported outcome measures (ClinROMs) for acne scars and dyspigmentation. For scars, 7 PROMs and 18 ClinROMs were used, with most being unvalidated. Similarly, for dyspigmentation, 4 PROMs and 8 ClinROMs were identified, but no validated PROMs were identified. These results highlight reliance on unvalidated measures in research and clinical trials and suggest the need for developing high-quality validated measures, particularly PROMs, to improve research quality and develop better treatments.

Indexed as

Acne VulgarisCicatrixHyperpigmentationPatient Reported Outcome MeasuresHumansQuality of LifeAcneClinROMDyspigmentationPROMScar

Identifiers

PMID40023366
PMCPMC12353528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.